NUCALA PRE-FILLED AUTOINJECTOR(2021-07-09)
- Starting date:
- July 9, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-76037
Last updated:
2021-07-15
Summary
-
Product:
NUCALA PRE-FILLED AUTOINJECTOR
Reason
Presence of foreign matter in the affected lot.
Depth of distribution
Retailers, Wholesalers
Affected products
NUCALA PRE-FILLED AUTOINJECTOR
DIN, NPN, DIN-HIM
DIN 02492989
Dosage form
Solution
Strength
MEPOLIZUMAB 100 MG / ML
Lot or serial number
JP3E, A73A
Companies
- Recalling Firm
-
GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4
- Marketing Authorization Holder
-
GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4